Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05706181 · ClinicalTrials.gov registry record · Phase 1
Heat Therapy, Functional Capacity, and Vascular Health in Older Adults
A Phase 1 study of Walking, Difficulty and Aging Well, sponsored by University of North Texas Health Science Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05706181: Recruiting Phase 1 study of Walking, Difficulty and Aging Well, sponsored by University of North Texas Health Science Center.
NCT05706181 is a Phase 1 study of Walking, Difficulty and Aging Well that is actively recruiting participants, run by University of North Texas Health Science Center. The registered enrollment target is 72 participants, below the 120-participant average among 12 other Walking, Difficulty trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05706181, a Phase 1 study of Walking, Difficulty and Aging Well, is actively recruiting participants, sponsored by University of North Texas Health Science Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
To test the hypothesis that home-based leg heat therapy improves functional capacity, vascular function, and exercise hyperemia in older adults.
Primary Outcome
The distance, in meters, covered while walking for 6 minutes will be used to assess functional capacity.
Conditions Studied
Interventions
- OTHER Home-based leg heat therapy
- OTHER Home-based sham therapy
Study Locations (1)
Texas
- University of North Texas Health Science Center - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-11-03 |
| Est. Completion | 2026-07-30 |
| Phase | Phase 1 |
What NCT05706181 shows while recruiting
NCT05706181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 120-participant average among 12 other Walking, Difficulty trials with a reported enrollment target (40% lower).
The record links to 3 conditions, with Walking, Difficulty appearing as the primary indexed condition, and to 2 interventions - of which Home-based leg heat therapy is the first listed.
NCT05706181 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05706181 about?
NCT05706181 is a clinical study titled "Heat Therapy, Functional Capacity, and Vascular Health in Older Adults". To test the hypothesis that home-based leg heat therapy improves functional capacity, vascular function, and exercise hyperemia in older adults.
What is the current status of trial NCT05706181?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2022-11-03. Estimated completion is 2026-07-30.
What conditions does trial NCT05706181 study?
This clinical trial studies the following conditions: Walking, Difficulty, Aging Well, Hyperemia.
What interventions are being tested in trial NCT05706181?
The interventions under investigation include: Home-based leg heat therapy (OTHER), Home-based sham therapy (OTHER).
Who is sponsoring clinical trial NCT05706181?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05706181 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Walking, Difficulty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05706181's enrollment target sits among peer trials
72 4th of 12 higher than 8 of 12 other Walking, Difficulty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Walking, Difficulty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
RECRUITING · NA
-
Biomarkers of Reaction To HIIT Exercise
RECRUITING · NA
-
Far Red Light to Improve Functioning in PAD
RECRUITING · NA
-
ENhancing Exercise with LIGHT to Improve Functioning in PAD
RECRUITING · NA
-
Fisetin to Reduce Senescence and Mobility Impairment in PAD
RECRUITING · Phase 2
-
Passive Stretching in Peripheral Arterial Disease Patients
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI